Mondelēz International has announced a collaboration with Israeli food-tech incubator The Kitchen to boost opportunities in the snacking segment.
When health workers in Malawi began rolling out the first vaccine proven to protect against malaria, it was a moment 32 years — and more than US$700 million — in the making.
Sygnature Discovery has announced a collaboration with software firm SilcsBio.
Researchers in Japan have demonstrated preserving frozen animal cells without a cryoprotectant agent, relying instead on ultrarapid cooling.
In an effort to provide a voice for people who can’t speak, neuroscientists have designed a device that can transform brain signals into speech.
Eli Lilly has announced that its humanised monoclonal antibody, Taltz (ixekizumab), yielded good results in a Phase III trial
Eli Lilly has announced that its humanised monoclonal antibody, Taltz (ixekizumab), yielded good results in a Phase III trial.
Eni SpA has signed an exploration and production agreement with the emirate of Ras Al Khaimah, a further push by the Italian company into the Middle East.
Finnish food company Fazer will build a €10.7 million facility in Finland capable of producing xylitol from oat hulls.
FrieslandCampina has opted to offload its Creamy Creation cream liqueur manufacturing business to Wagram Equity Partners, a Dutch private investment company.